Erasca (ERAS) Shares Issued (2020 - 2026)
Erasca posted quarterly Shares Issued of $258.8 million for Q1 2026, up 783990.91% year-on-year from N/an in Q1 2025, and up 101370.59% on a QoQ basis from $255000.0 in Q4 2025.
Erasca (ERAS) has 7 years of Shares Issued data on file, last reported at $258.8 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Issued rose 783990.91% year-over-year to $258.8 million; the trailing twelve-month figure through Mar 2026 stood at $259.1 million (up 1008.67% YoY), and the FY2025 full-year result was $372000.0, down 55.5% from the prior year.
- Shares Issued for Q1 2026 stood at $258.8 million, up from $255000.0 in the prior quarter.
- Across five years, Shares Issued topped out at $258.8 million in Q1 2026 and bottomed at -$42.8 million in Q4 2024.
- The 5-year median for Shares Issued is $193000.0 (2023), against an average of $19.7 million.
- The widest annual swing landed in 2024, when Shares Issued plunged 22259.59%; it then surged 783990.91% in 2026.
- A 5-year view of Shares Issued shows it stood at $94.9 million in 2022, then tumbled by 99.8% to $193000.0 in 2023, then slumped by 22259.59% to -$42.8 million in 2024, then surged by 100.6% to $255000.0 in 2025, then jumped by 101370.59% to $258.8 million in 2026.
- The last three Shares Issued figures came in at $258.8 million (Q1 2026), $255000.0 (Q4 2025), and $41000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Erasca | 4.21 Bn | 3.97 Bn | - | 258.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 258.75 Mn |
| Mar 31, 2026 | 258.75 Mn |
| Dec 31, 2025 | 255,000.00 |
| Dec 31, 2025 | 255,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 43,000.00 |
| Jun 30, 2025 | 43,000.00 |
| Mar 31, 2025 | 33,000.00 |
| Mar 31, 2025 | 33,000.00 |
| Dec 31, 2024 | -42.77 Mn |
| Dec 31, 2024 | -42.77 Mn |
| Sep 30, 2024 | 21.00 Mn |
| Sep 30, 2024 | 21.00 Mn |
| Jun 30, 2024 | -6.78 Mn |
| Jun 30, 2024 | -6.78 Mn |
| Mar 31, 2024 | 6.91 Mn |
| Mar 31, 2024 | 6.91 Mn |
| Dec 31, 2023 | 193,000.00 |
| Dec 31, 2023 | 193,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Jun 30, 2023 | 122,000.00 |
| Jun 30, 2023 | 122,000.00 |
| Mar 31, 2023 | 183,000.00 |
| Mar 31, 2023 | 183,000.00 |
| Dec 31, 2022 | 94.90 Mn |
| Dec 31, 2022 | 94.90 Mn |
| Sep 30, 2022 | 427,000.00 |
| Sep 30, 2022 | 427,000.00 |
| Jun 30, 2022 | 375,000.00 |
| Jun 30, 2022 | 375,000.00 |
| Mar 31, 2022 | 460,000.00 |
| Mar 31, 2022 | 460,000.00 |
| Sep 30, 2021 | 315.68 Mn |
| Sep 30, 2021 | 315.68 Mn |
| Jun 30, 2021 | 180,000.00 |
| Jun 30, 2021 | 180,000.00 |
| Mar 31, 2021 | 1.14 Mn |
| Mar 31, 2021 | 1.14 Mn |
| Dec 31, 2020 | -112,000.00 |
| Dec 31, 2020 | -112,000.00 |
| Sep 30, 2020 | 2.64 Mn |
| Sep 30, 2020 | 2.64 Mn |